Mtss1 is a critical epigenetically regulated tumor suppressor in CML
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mtss1 is a critical epigenetically regulated tumor suppressor in CML
Authors
Keywords
-
Journal
LEUKEMIA
Volume 30, Issue 4, Pages 823-832
Publisher
Springer Nature
Online
2015-12-01
DOI
10.1038/leu.2015.329
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Missing-in-Metastasis regulates cell motility and invasion via PTPδ-mediated changes in SRC activity
- (2015) Fauzia Chaudhary et al. BIOCHEMICAL JOURNAL
- Downregulation of MTSS1 expression is an independent prognosticator in squamous cell carcinoma of the lung
- (2015) G Kayser et al. BRITISH JOURNAL OF CANCER
- EGF induces microRNAs that target suppressors of cell migration: miR-15b targetsMTSS1in breast cancer
- (2015) Merav Kedmi et al. Science Signaling
- EGF induces microRNAs that target suppressors of cell migration: miR-15b targetsMTSS1in breast cancer
- (2015) Merav Kedmi et al. Science Signaling
- Identification of the Adapter Molecule MTSS1 as a Potential Oncogene-Specific Tumor Suppressor in Acute Myeloid Leukemia
- (2015) Mirle Schemionek et al. PLoS One
- SCFβ-TRCP targets MTSS1 for ubiquitination-mediated destruction to regulate cancer cell proliferation and migration
- (2015) Jiateng Zhong et al. Oncotarget
- Whole genome expression profiling of blood cells in ovarian cancer patients -Prognostic impact of the CYP1B1, MTSS1, NCALD, and NOP14 genes
- (2015) Helena S. Isaksson et al. Oncotarget
- Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche
- (2014) D. S. Krause et al. BLOOD
- The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem/progenitor cells
- (2014) K. Rothe et al. BLOOD
- MTSS1 is a metastasis driver in a subset of human melanomas
- (2014) Kirsten D. Mertz et al. Nature Communications
- Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells
- (2013) E. Bolton-Gillespie et al. BLOOD
- Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt- -catenin signaling
- (2013) B. Zhang et al. BLOOD
- PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells
- (2013) Paolo Neviani et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer
- (2013) Weiyun Wu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles
- (2013) Anthony Mathelier et al. NUCLEIC ACIDS RESEARCH
- Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis
- (2013) R Lei et al. ONCOGENE
- Dimerization is necessary for MIM-mediated membrane deformation and endocytosis
- (2012) Meng Cao et al. BIOCHEMICAL JOURNAL
- MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma
- (2012) Jian Wang et al. BMC CANCER
- Knock-down of Kaiso induces proliferation and blocks granulocytic differentiation in blast crisis of chronic myeloid leukemia
- (2012) Jaime Cofre et al. Cancer Cell International
- The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells
- (2012) Haojian Zhang et al. NATURE GENETICS
- Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease
- (2011) C. Elling et al. BLOOD
- CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia
- (2011) H. Makishima et al. BLOOD
- Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival
- (2011) A. Hamilton et al. BLOOD
- Low BCR-ABL expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinib
- (2011) A. Kumari et al. BLOOD
- Procoagulant activity induced by vascular injury determines contribution of elevated factor VIII to thrombosis and thrombus stability in mice
- (2011) K. R. Machlus et al. BLOOD
- Rho Kinase Regulates the Survival and Transformation of Cells Bearing Oncogenic Forms of KIT, FLT3, and BCR-ABL
- (2011) Raghuveer Singh Mali et al. CANCER CELL
- IRF8 Regulates Acid Ceramidase Expression to Mediate Apoptosis and Suppresses Myelogeneous Leukemia
- (2011) X. Hu et al. CANCER RESEARCH
- BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
- (2011) Christian Hurtz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The impact of Metastasis Suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance
- (2011) Fei Xie et al. Journal of Translational Medicine
- Role of stromal microenvironment in nonpharmacological resistance of CML to imatinib through Lyn/CXCR4 interactions in lipid rafts
- (2011) Y Tabe et al. LEUKEMIA
- Leukemic spleen cells are more potent than bone marrow-derived cells in a transgenic mouse model of CML
- (2011) M Schemionek et al. LEUKEMIA
- Mice deficient in MIM expression are predisposed to lymphomagenesis
- (2011) D Yu et al. ONCOGENE
- MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma
- (2011) H Fan et al. ONCOGENE
- BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells
- (2010) M. Schemionek et al. BLOOD
- Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor
- (2010) Y. Benita et al. BLOOD
- Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
- (2010) Amie S. Corbin et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group
- (2010) Torsten Haferlach et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanaomycin A Selectively Inhibits DNMT3B and Reactivates Silenced Tumor Suppressor Genes in Human Cancer Cells
- (2010) D. Kuck et al. MOLECULAR CANCER THERAPEUTICS
- A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
- (2010) Paul W. Hollenbach et al. PLoS One
- MOODS: fast search for position weight matrix matches in DNA sequences
- (2009) J. Korhonen et al. BIOINFORMATICS
- Finding evolutionarily conserved cis-regulatory modules with a universal set of motifs
- (2009) Bartek Wilczynski et al. BMC BIOINFORMATICS
- An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase
- (2008) Alexander Kohlmann et al. BRITISH JOURNAL OF HAEMATOLOGY
- Rac GTPases as key regulators of p210-BCR-ABL-dependent leukemogenesis
- (2008) E K Thomas et al. LEUKEMIA
- Anomalous dynamics of cell migration
- (2008) P. Dieterich et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started